A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce

See also
Status	Clinical Trial	Phase
Recruiting	`NCT04169100` - Novel Form of Acquired Long QT Syndrome	Phase 4
Enrolling by invitation	`NCT03683186` - A Study Evaluating the Long-Term Efficacy and Safety of Ralinepag in Subjects With PAH Via an Open-Label Extension	Phase 3
Active, not recruiting	`NCT03688191` - Study of Sirolimus in CTD-TP in China	Phase 4
Completed	`NCT00004357` - Absorption of Corticosteroids in Children With Juvenile Dermatomyositis	Phase 2
Recruiting	`NCT04918524` - The Clinical Features and Pregnancy Outcomes of CTD Patients
Recruiting	`NCT04993885` - Avatrombopag in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies	Phase 2
Not yet recruiting	`NCT05998759` - Telitacicept for the Treatment of Connective Tissue Disease-associated Thrombocytopenia	Phase 2
Recruiting	`NCT05065814` - Connective Tissue Diseases and Vitamin D Deficiency	N/A
Completed	`NCT03494036` - Effect of Synbiotic on Immune Response, Gut Permeability and Microbiota in Patient With Connective Tissue Disease	N/A
Completed	`NCT03929120` - Allogeneic Bone Marrow Mesenchymal Stem Cells for Patients With Interstitial Lung Disease (ILD) & Connective Tissue Disorders (CTD)	Phase 1
Completed	`NCT00001330` - Study of Silicone-Associated Connective Tissue Diseases	N/A
Not yet recruiting	`NCT05980728` - Connective Tissue Disease Patients With Pulmonary Hypertension
Not yet recruiting	`NCT04582292` - Laryngeal Manifestations of Connective Tissue Diseases
Completed	`NCT06458803` - Efficacy and Safety of Eltrombopag for Refractory Thrombocytopenia Associated With Connective Tissue Disease
Recruiting	`NCT03214263` - Identification of New Biomarkers to Promote Personalized Treatment of Patients With Inflammatory Rheumatic Diseases
Completed	`NCT04171362` - The Effect of Connective Tissue Massage in Patients With Migraine	N/A
Completed	`NCT01656278` - An MRI-guided Treatment Strategy to Prevent Disease Progression in Patients With Rheumatoid Arthritis	N/A
Recruiting	`NCT04915482` - TPO-RAs Combined With Anti-CD20 Antibody in the Treatment of Adult Immune Thrombocytopenia With Autoantibodies	Phase 2/Phase 3
Recruiting	`NCT05505409` - Efficacy and Safety of Pirfenidone in CTD-ILD	Phase 4
Recruiting	`NCT02768259` - Prevalence of Pulmonary Arterial Hypertension in Patients With Connective Tissue Diseases in Egyptian Patients	N/A

NCT number	NCT02392130
Study type	Interventional
Source	LEO Pharma
Contact
Status	Completed
Phase	Phase 1
Start date	March 2015
Completion date	June 2015

A Clinical Trial to Assess the Potential of LEO 130852A Gel to Reduce Steroid Induced Skin Atrophy on Healthy Skin

Clinical Trial Summary

Clinical Trial Description

Study Design

Related Conditions & MeSH terms